In this week’s video, Dr. Brian Durie provides insight on how to assess response to various myeloma treatments.
By checking M-protein levels after each cycle of treatment, we can assess the true benefits of each therapy.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.